naltrexone has been researched along with Multiple Sclerosis, Chronic Progressive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bucello, S; Cavarretta, R; Comi, G; Cursi, M; Franchi, S; Gironi, M; Martinelli, V; Martinelli-Boneschi, F; Martino, G; Moiola, L; Nemni, R; Pilato, V; Radaelli, M; Rodegher, M; Sacerdote, P; Solaro, C; Zaffaroni, M | 1 |
| Kashipazha, D; Majdinasab, N; Moghtaderi, A; Shalbafan, B; Sharafaddinzadeh, N | 1 |
1 trial(s) available for naltrexone and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Naltrexone; Narcotic Antagonists; Quality of Life; Surveys and Questionnaires; Young Adult | 2010 |
1 other study(ies) available for naltrexone and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.
Topics: Adolescent; Adult; Aged; Depression; Disabled Persons; Fatigue; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Naltrexone; Pilot Projects; Polymorphism, Single Nucleotide; Receptors, Opioid, mu; RNA, Messenger | 2008 |